A method to identify chemical scaffolds potentially active against Mycobacterium tuberculosis is presented. The molecular features of a set of structurally heterogeneous antituberculosis drugs were coded by means of structural invariants. Three techniques were used to obtain equations able to model the antituberculosis activity: linear discriminant analysis, multilinear regression, and shrinkage estimation-ridge regression. The model obtained was statistically validated through leave-n-out test, and an external set and was applied to a database for the search of new active agents. The selected compounds were assayed in vitro, and among those identified as active stand reserpine, N,N,N′,N′-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN), trifluoperazine, pentamidine, and 2-methyl-4,6-dinitro-phenol (DNOC). They show activity comparable to or superior to ethambutol, used in combination with other drugs for the prevention and treatment of Mycobacterium avium complex and drug-resistant tuberculosis. (Journal of Biomolecular Screening 2005:206-214) 
INTRODUCTION

I
NFECTIONS CAUSED BY MYCOBACTERIUM TUBERCULOSIS (MTB) are difficult to treat, especially the cases associated with multi-drug-resistant strains. This is particularly alarming because these diseases have become an increasingly significant public health problem in both developed and nondeveloped countries in recent years. New compounds potentially active against these bacteria are therefore constantly being sought. 1, 2 However, no new treatments have been released in the past years, so new drugs that can be used for treatment and prophylaxis for these diseases are necessary.
Most of the currently available drug design methods require a previous knowledge of the mechanism of action involved, but in most cases, this information is limited. Extramechanistical approaches have been used to design new drugs, model toxicities, and find common structural patterns of the known drugs. [3] [4] [5] [6] [7] [8] Some of these models are entirely based on the search of common patterns of molecular similarity and have been used for the selection and design of new analgesics, 9 beta-blockers, 10 sedatives, 11 bronchodilators, 12 antihistaminics, 13 antivirals, 14 antibacterials, 15 cytostatics, 16 antimycobacterials, 17 and antifungals, 18, 19 many of which can be considered as lead drugs. They have been also successful in the prediction of diverse properties, such as chromatographic, 20 physicochemical, 21, 22 soil-sediment sorption coefficients, 23 or drug transfer into breast milk. 24 General reviews on topological indices and their applications can be found in references Selassie and others, 5 Randic! , 7 Bonchev, 25 Estrada and Uriarte, 26 and Gozalbes and others. 27 On the other hand, many studies have been published on the quantitative structure-activity relationship (QSAR) applied to antituberculosis compounds, although no revision in this field has, up to now, appeared. Thus, the groups studied comprise hydrazine derivatives, [28] [29] [30] [31] pyridines, [32] [33] [34] xanthones, [35] [36] [37] benzoxamines, and related 38, 39 pyrroles, 40 pteridines, 41 steroids, 42 and phenyl carbamates. 43 The aim of this study was to develop a molecular pattern model, based on structural invariants, to select potential agents against M. tuberculosis, which might involve new chemical scaffolds useful for the development of new lead drugs.
The proposed model was constituted by linear equations acting as filters. A molecular structure would be proposed for the in vitro assay if its values for every equation were within predefined intervals. Three kinds of equations were obtained: derived from linear discriminant analysis (LDA), derived from multilinear regression analysis (MLRA), and obtained by shrinkage/ridge regression.
MATERIALS AND METHODS
Descriptors
A group of compounds with known anti-MTB activities was built up from several sources. [44] [45] [46] [47] [48] The values taken as dependent variables for the regression analyses were averaged from the ranges given by different authors. Each compound was characterized by a set of 74 structural invariants, 49 calculated by the program Descrip. 50 These indices were a) 16 49 and f) 10 other discrete invariants. 49 The main part of the descriptors used is constituted by graphtheoretical indices. Some concepts are sketched here to better understand their definitions. First, the molecular structure is abstracted as a chemical graph in which nonhydrogen atoms are represented as vertices and bonds are represented as edges. Multiple bonds are represented by multiple edges. A labeled chemical graph is the representation of what chemists understand qualitatively as the chemical structure. A graph can be mathematically represented by its adjacency matrix A, in which elements a ij are the count of σ and π bonds between the atoms numbered as i and j. Degree is the number of edges that converge in a vertex. Substructures such as functional groups or radicals can also be represented as subgraphs. The order of a subgraph is the number of edges that appear in it. A subgraph of type path (p) is formed by a linear succession of vertices with 2 different ends, a subgraph of type cluster (c) is formed by a vertex adjacent to the others, and a path-cluster (pc) subgraph can be defined as an acyclic graph that is not a p or a c. Topological distance is the distance between pairs of vertices in terms of bonds.
The following types of indices, described here in order of increasing complexity, have been used. Discrete invariants. They are natural numbers calculated from chemical graphs.
N, molecular size. Number of graph vertices.4 9 Vk, vertices of degree k, where k is 3 or 4. Number of vertices of degree k.4 9 R, ramification. Number of single structural branches.4 9 W, Wiener paths number. Sum of topological distances in the graph.5 3 L, length. Maximal topological distance in the graph.4 9 PRk, pairs of ramifications at distance k, where k is between 0 and 3.
Number of pairs of single branches at topological distance k. 4 9 Topologic-geometrical indices. The surface parameter S is calculated through group contributions after Gálvez and others. 49 The shape index E is simply calculated as E = S/(L , where δ i is the degree of the atom i, S j is the jth subgraph of order k and type t, and k n t is the total number of subgraphs of order k and type t that can be identified in the molecular structure. The types used were p, c, and pc. Subgraphs of order lower than 3 are unique, and the label t is omitted in their corresponding indices.
Kier-Hall valence connectivity indices. 
Combinations of indices.
The following indices, calculated by operations with the former ones, were also used:
Modeling
The greater number of filters, the more selective the search is. The model will consist of 4 equations. Two discriminant equations were obtained following different criteria for the selection of the training actives set. The other 2 equations were regression equations for the MIC obtained by 2 different methods.
Linear discriminant analysis
Two groups of compounds are considered in LDA. In this case, the 1st group included anti-MTB drugs and the 2nd inactive compounds. The nonactive molecules were chosen from the Merck Index and Sigma-Aldrich databases among chemicals and drugs of other therapeutic categories. It is not known if these compounds actually present antituberculosis activity, but the assumption that they were inactive seems reasonable because it has not been reported as yet.
The independent variables in this study were the calculated descriptors, and the discrimination property was the presence or absence of anti-MTB activity. LDA was performed with the BMDP package. 54 A 1st equation, DFa, comprised 36 substances with known antituberculosis activity. A 2nd one, more restrictive, DFb, was calculated with 25 drugs used actually against tuberculosis worldwide.
Multilinear regression analysis
The MLRA was performed with the BMDP program. 54 The property MIC 90 against MTB, expressed in mg/L and µM, as well as their respective logarithms, was correlated versus descriptors to select the best regression equations. Optimal descriptor subsets were selected by means of the Furnival-Wilson algorithm. 55 Equations with the minimal Mallows' Cp parameter 56 were initially chosen.
Shrinkage estimation-ridge regression
To select a 2nd regression equation, ridge-shrinkage regression was attempted with the program Rxridge. 57 This is a method recommended when nonorthogonal descriptors are involved. In ridge regression, a constant is added to the diagonal of X t X (correlation matrix), which is then restandardized so that all diagonal elements are equal to 1 and the off-diagonal elements are reduced. 58 This reduces the effects of multiple colinearity so that the influence of each independent variable on the dependent variable can be seen. Correlation coefficients are decreased, and more stable estimates can be computed. Each regression coefficient k of the principal components results multiplied by a shrinkage factor is equal to
, where c is the ridge factor, λ k is the corresponding eigenvalue of the covariance matrix, and Q is the coefficient ridge trace that determines the shape of the shrinkage pattern. An optimal Q is suggested by normal maximum likelihood.
Microbiological study
Thirty-two clinical isolates of M. tuberculosis from respiratory (n = 21) and nonrespiratory (n = 11) clinical samples, identified by a DNA hybridization probe (Accuprobe ® Gen Probe Inc., San Diego, CA) and conventional methods, 59 were selected from the laboratory collection of Departamento de Microbiología, Hospital Clínico Universitario (Valencia, Spain).
Susceptibility to 1st-line antituberculosis drugs (isoniazid, rifampin, ethambutol, and streptomycin) was tested by a fluorometric method (Bactec ® MGIT 960, Becton-Dickinson, Sparks, MD) and by a proportion method. Four out of the 32 MTB tested strains were resistant to at least 1 first-line antituberculosis drug (1 isolate to streptomycin, 2 isolates to isoniazid, and 1 isolate to both isoniazid and rifampin), and the 28 remaining were fully susceptible. These results are comparable to the sensibility breakpoints found in the bibliography for these antibiotics, 59 which validates the method followed as well as the susceptibility/resistance of the strains tested.
The organisms were grown in modified Middlebrook 7H9 broth supplemented with 10% OADC enrichment (Difco Laboratories, Detroit, MI) for 7 d at 37°C. The inoculum's size was obtained by dilution of M. tuberculosis isolate suspensions in 7H9 broth to yield an absorbance equivalent to that of a MacFarland no. 0.5 standard.
Antimicrobial susceptibility test was performed in 96-well microplates using serial 2-fold microdilution in 7H9 broth. Initial drug dilutions were prepared in deionized water or, if not soluble, DMSO. Subsequent 2-fold dilutions were performed in 150 µL of modified 7H9 broth in the microplates to provide a final test range of 128 to 0.125 mg/L. Then, 10 µL of a suspension of mycobacteria was added to the wells. Plates were covered with Parafilm "M" ® (Laboratory Film, American National Can TM, Menasha, WI) and incubated for 12 d at 37°C. Starting on day 13 of incubation, 20 µL of Resazurina ® (Sigma 2127) with a concentration of 250 mg/L was added to the wells, and the microplates were reincubated at 37°C
for an additional period of 48 h. MIC 50 and MIC 90 were determined as the lowest concentrations of the compounds yielding no visible changes from blue to pink. This method is analogous to the one that has been previously published, 60 except that the incubation time was 12 d.
RESULTS AND DISCUSSION
Modeling
Linear discriminant analysis
The following discriminant equations-respectively, DFa and DFb-were obtained: (2) where N = 60 represents 25 anti-MTB drugs and 35 presumably inactive compounds. Each equation classifies a compound as active or inactive if its value is positive or negative, respectively. The classification results for the active and inactive groups-for equations (1) and (2), respectively-are given in the supplementary materials. Also given are the values of the respective DF as well as the calculated probabilities of pertaining to their respective group for each substance. These probabilities are basically proportional to the Mahalanobis distance from the data points to the centroid, the point that represents the means for all variables in the multivariate space defined by the group. The linear equations gave good discrimination because most compounds were classified with a probability more than 80% by DFa and more than 90% by DFb. The error percentage by DFa was about 14% in the active set and about 6% in the inactive set, whereas by DFb, it was about 8% and 0%, respectively. Curiously, compounds present in the training set of DFa, active but not actually used as antitubercular drugs, generally obtained lower probabilities of activity with this function.
To choose intervals of these equations in which the active compounds accumulated, pharmacological activity distribution diagrams (PDDs) were used. 61 These are histogram-like plots of calculated values of the mathematical function in which expectancies appear on the ordinate axis. For an arbitrary interval of values of a given function, the expectancy of activity is Ea = a/(i + 100), where a is the percentage of active compounds in the interval, and i is the corresponding percentage of inactive compounds within the same interval. The expectancy of inactivity is defined likewise as Ei = i/ (a + 100). Figure 1 shows the PDDs obtained from DFa and DFb. As can be seen, the optimal DFa range to find active compounds is between 0 and 6, whereas by DFb, it is between 0 and 4.5.
The validation of the selected DFs was performed by 2 methods. The first was an internal leave-n-out test. The 2nd method was the prediction in an external test set of no previously used data.
Validation by internal test. In the leave-n-out test, the results for training and test groups were within the same range. The average percentage of success obtained with the training group for DFa was 81% for active and 85% for inactive. For the test, it was 84% and 85%, respectively. The average percentage of success obtained with the training group for DFb was 87% for active and 96% for in- active. For the test, it was 80% and 92%, respectively. The results were similar to the ones obtained with DFa and DFb equations, which points out the validity of equations (1) and (2). Tables showing the results of internal validation obtained for DFa and DFb can be found in the supplementary materials.
Validation on external set. DFa and DFb were applied to compounds, active and inactive, which were not used in training. Tables showing the results of external validation obtained for DFa and DFb can be found in the supplementary materials.
In the external validation test, only 2 active compounds were erroneously classified: rifabutin by DFa and ethionamide by DFb. The same stands in the group of inactives, where doxorubicin for DFa and glucosamine for DFb were misclassified.
Multilinear regression analysis
The best linear regression equations obtained were MIC 90 , expressed in mg/L (see Table 1 ). The same activity expressed in µM was not so well correlated. One explanation could be that the descriptors used were obtained by summations of fragment contributions. Thus, they are not absolutely independent from the molecular mass. The use of molar magnitudes introduces a redundant factor. In relation to the logarithmic correlations, they usually give better results with variables that range several magnitude orders, which is not the case.
The selected equation and its statistical parameters were Validation in internal set and stability. To test the predictive potential of equation (3), a cross-validation leave-n-out analysis (CV) was performed. 62 By eliminating n cases and carrying out again the regression analysis with the remaining, the values for the discarded compounds were predicted. This process was repeated several times. The validation was performed for n = 1, 5, and 9, which corresponds with 2%, 10%, and 20% of the compounds, respectively. It showed good stability: for n = 1, 5, and 9, r 2 took the values 0.697, 0.695, and 0.692, respectively.
The results obtained from the stability analysis for equation (3), as well as the predictions by equation (3), are shown in the supplementary materials. The results state the stability of the regression residuals versus cross-validation residuals. The prediction success of equation (3) was satisfactory, and it can distinguish between low and high values of Pa.
Shrinkage estimation-ridge regression
The selection of variables was stepwise. First, regression was performed with ridge regression parameter 0.999, and an equation with 9 variables was selected: L, Validation in internal set and stability. A stability test similar to the one corresponding to equation (3) was also performed with equation (4) . It showed good stability: for n = 1, 5, and 9, r 2 took the values of 0.635, 0.636, and 0.618, respectively.
The results obtained from the stability analysis for equation (4) are shown in Figure 2 . This reflects the stability of the regression equation residuals versus cross-validation residuals.
Calculated values of Pb and the results of the leave-n-out test can be seen in the supplementary material.
Computational screening
The equations obtained and their corresponding intervals constitute a model for the filtering of databases. If a molecule has its values for the equations within the thresholds, it is selected as potentially active. That is, if 0 < DFa < 6, 0 < DFb < 4.5, and 0 < P < 16 mg/L, then the chemical structure is chosen.
A virtual screening with the MTB model to select potentially active molecules was carried out. A homemade database of around 5000 structurally heterogeneous compounds was used. Molecular structures were selected from the Merck Index and the SigmaAldrich catalogue, attending to their drug-like character, which was estimated after the method published in Gálvez and others. 4 The model was able to select 18 candidate molecules. To check the predicted antituberculosis activity of the selected new compounds, microbiological tests were performed. Table 2 shows the equation values for the selected compounds, MIC 90 expressed in mg/L and µM and the experimental MIC range (minimal and maximal inhibitory values). Figure 2 shows the plots of the calculated values against the measured values for Pa and Pb, respectively, including data from the training set as well as the finally selected compounds. Despite the care paid in selecting equations that were capable of making true predictions, MICs of the selected compounds were, in general, poorly predicted. However, the method has been able to identify active compounds in a database of commercial compounds in which no active compounds were expected. In general, the selected compounds have molecular structures that are new in the field of antituberculosis agents. Some of the selected compounds-linezolid, paromomycin, reserpine, and trifluoperazine-have been described as active substances against some Mycobacterium species. For these compounds, it has been checked that theoretical calculations of activity are comparable to those obtained in vitro and to those reported by other groups. Linezolid represents a novel chemical class of synthetic antimicrobial agents, the oxazolidinones, which acts by inhibiting the initiation of bacterial protein synthesis. This antibiotic has a wide spectrum of activity against aerobe gram-positive organisms and against some anaerobes and mycobacteria. 63 Paromomycin is an oligosaccharide-type antibiotic with demonstrated antibacterial and antiamoebic activity, 6 4 and trifluoroperazine is a phenotiazine employed in the treatment of psychosis, which has demonstrated in vitro growth inhibition of M. tuberculosis strains. 65 It is noteworthy that none of these substances was in the training group. Thus, their rediscovery cannot be considered a chance effect, and the ability of the model to find new active structures is stated.
The most active compound was linezolid, with MIC 90 = 770 nM ( Table 2 ). The other 3 substances (reserpine, N,N,N′,N′-tetrakis-(2-pyridylmethyl)-ethylenediamine [TPEN] , and trifluoperazine) gave activity values (13, 19 , and 20 µM, respectively) greater than or equal to one of the reference tuberculostatics, ethambutol (20 µM after the method followed). Pentamidine, paromomycin, benzalkonium chloride (BAK), and 2-methyl-4,6-dinitro-phenol (DNOC) showed MIC 90 values lower than 100 µM. The structures of these compounds are displayed in Figure 3 . The remainder gave lower activity.
It must be specially pointed out that the structures of reserpine, TPEN, pentamidine, and DNOC are suggestive of new chemical scaffolds due to their novelty in the field and relatively low toxicity. In addition, reserpine and pentamidine are drugs used in other therapeutic fields. Their use in tuberculosis treatment would be accelerated because the results of many tests required for a new drug are already known. Our research group is studying the synergistic effects of these substances with known antituberculosis drugs.
The importance of this study relies on the fact that in recent years, no new antituberculosis agents have been released. Modified substitutions in the structures of the molecules selected could eventually afford new potential agents in this field, which could be developed within combinatorial chemistry research programs. By contrast, the standard substructure search rends trivial structures that are slight variations of the known ones. The method used here gives novel structures that are not apparently related with the training group ones. Thus, it generates more diverse molecules. Several action mechanisms have been considered in the training group, including targeting to latent bacteria. However, the validity of the approach is appreciable. Clearly, the model retains the structural features involved in all the mechanisms considered. It can be concluded that it is possible to obtain new unexpected molecular structures acting through the known mechanisms that combine properties and structural features of the known compounds. This fact could be useful in preventing resistance problems.
SUPPLEMENTARY MATERIAL
Supplementary information is available upon request from the authors (julian@goya.combios.es): tables with the values of the selected equations for the molecular sets used and results of the validation methods.
